FDA calendars are public. Do not invent an approval in a notice.

FDA user-fee calendars and advisory-committee agendas are posted by the agency. Those pages are the place to learn what a committee will discuss. This briefing is not an approval, a complete-response letter, or a label. A company that wants the public to know it has a meeting on a calendar can say that in original sentences and link the official docket. A close rewrite of an FDA talk paper is still FDA’s talk paper. Notice Nearby will not seed a fake drug approval as if it were a paid press release. The topic here is process: calendars exist, dockets exist, and filers should point at them instead of inventing outcomes. Editorial only. No Stripe payment. — Publisher desk rewrite. Original Notice Nearby copy about a public topic. Not a paid $79 placement and not a Stripe checkout.